Cargando…
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily being expressed as a cell surface molecule and binding a variety of ligands. One of these ligands is high-mobility group box chromosomal protein 1, a potent proinflammatory cytokine, expression of w...
Autores principales: | Pullerits, Rille, Bokarewa, Maria, Dahlberg, Leif, Tarkowski, Andrej |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175032/ https://www.ncbi.nlm.nih.gov/pubmed/15987483 http://dx.doi.org/10.1186/ar1749 |
Ejemplares similares
-
Low Soluble Receptor for Advanced Glycation End Products Precedes and Predicts Cardiometabolic Events in Women With Rheumatoid Arthritis
por: Nadali, Mitra, et al.
Publicado: (2021) -
Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis
por: Bokarewa, Maria, et al.
Publicado: (2005) -
Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis
por: Wasén, Caroline, et al.
Publicado: (2018) -
Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis
por: Osborn, Teresia M, et al.
Publicado: (2008) -
Clinical Significance of Diabetes-Mellitus-Associated Antibodies in Rheumatoid Arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2022)